EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 203 / Numéro 4 (2009) J. Soc. Biol., 203 4 (2009) 303-310 Références
Accès gratuit
Numéro
J. Soc. Biol.
Volume 203, Numéro 4, 2009
Page(s) 303 - 310
Section Comment et pourquoi s'est construit le système rénine-angiotensine au cours de l'évolution ?How and why did the renin-angiotension sytem build up during evolution?
DOI https://doi.org/10.1051/jbio/2009034
Publié en ligne 1 février 2010
  • Adams J.P., Sweatt J.D., Molecular psychology : roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol, 2002, 42, 135-163. [CrossRef] [PubMed] [Google Scholar]
  • Amsterdam A., Nissen R.M., Sun Z., Swindell E.C., Farrington S., Hopkins N., Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA, 2004, 101, 12792-12797. [CrossRef] [Google Scholar]
  • Batenburg W.W., Krop M., Garrelds I.M., de Vries R., de Bruin R.J., Burcklé C.A., Müller D.N., Bader M., Nguyen G., Danser A.H., Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hyperten., 2007, 25, 2441-2453. [CrossRef] [Google Scholar]
  • Burcklé C.A., Jan Danser A.H., Müller D.N., Garrelds I.M., Gasc J.M., Popova E., Plehm R., Peters J., Bader M., Nguyen G., Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension, 2006, 47, 552-556. [CrossRef] [PubMed] [Google Scholar]
  • Campbell D.J., Valentijn A.J., Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors. J Hypertens, 1994, 12, 879-890. [PubMed] [Google Scholar]
  • Danser A.H., van Kats J.P., Admiraal P.J., Derkx F.H., Lamers J.M., Verdouw P.D., Saxena P.R., Schalekamp M.A., Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension, 1994, 24, 37-48 [Google Scholar]
  • Danser A.H., Saris J.J., Schuijt M.P., van Kats J.P., Is there a local renin-angiotensin system in the heart? Cardiovasc Res, 1999, 44, 252-265. [Google Scholar]
  • Deinum J., Rønn B., Mathiesen E., Derkx F.H., Hop W.C., Schalekamp M.A., Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia, 1999, 42, 1006-1010. [CrossRef] [PubMed] [Google Scholar]
  • Derkx F.H., Deinum J., Lipovski M., Verhaar M., Fischli W., Schalekamp M.A., Nonproteolytic “activation” of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibody. J Biol Chem, 1992, 267, 22837-22842. [PubMed] [Google Scholar]
  • Dostal D.E., Baker K.M., The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? Circ Res, 1999, 1, 85, 643-650. [Google Scholar]
  • Feldman D.L., Jin L., Xuan H., Contrepas A., Zhou Y., Webb R.L., Mueller D.N., Feldt S., Cumin F., Maniara W., Persohn E., Schuetz H., Jan Danser A.H., Nguyen G., Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension, 2008, 52, 130-136. [CrossRef] [PubMed] [Google Scholar]
  • Fisher N.D., Jan Danser A.H., Nussberger J., Dole W.P., Hollenberg N.K., Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Circulation, 2008, 117, 3199-3205. [CrossRef] [PubMed] [Google Scholar]
  • Huang Y., Wongamorntham S., Kasting J., McQuillan D., Owens R.T., Yu L., Noble N.A., Border W., Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int, 2006, 69, 105-113. [CrossRef] [PubMed] [Google Scholar]
  • Huang Y., Noble N.A., Zhang J., Xu C., Border W.A., Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int, 2007, 72, 45-52. [CrossRef] [PubMed] [Google Scholar]
  • Ichihara A., Hayashi M., Kaneshiro Y., Suzuki F., Nakagawa T., Tada Y., Koura Y., Nishiyama A., Okada H., Uddin M.N., Nabi A.H., Ishida Y., Inagami T., Saruta T., Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin. J Clin Invest, 2004, 114, 1128-1135. [PubMed] [Google Scholar]
  • Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Suzuki F., Nakagawa T., Nishiyama A., Inagami T., Hayashi M., Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension, 2006, 47, 894-900. [CrossRef] [PubMed] [Google Scholar]
  • Kaneshiro Y., Ichihara A., Takemitsu T., Sakoda M., Suzuki F., Nakagawa T., Hayashi M., Inagami T., Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int, 2006, 70, 641-646. [CrossRef] [PubMed] [Google Scholar]
  • Kaneshiro Y., Ichihara A., Sakoda M., Takemitsu T., Nabi A.H., Uddin M.N., Nakagawa T., Nishiyama A., Suzuki F., Inagami T., Itoh H., Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol, 2007, 18, 1789-1795. [CrossRef] [PubMed] [Google Scholar]
  • Katz S.A., Opsahl J.A., Lunzer M.M., Forbis L.M., Hirsch A.T., Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium. Hypertension, 1997, 30, 259-66. [PubMed] [Google Scholar]
  • Krebs C., Hamming I., Sadaghiani S., Steinmetz O.M., Meyer-Schwesinger C., Fehr S., Stahl R.A., Garrelds I.M., Danser A.H., van Goor H., Contrepas A., Nguyen G., Wenzel U., Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of glodblatt hypertensive rats. Kidney Int, 2007, 72, 725-730. [CrossRef] [PubMed] [Google Scholar]
  • Krzesinski J.M., Montrieux C.h., Scheen A.J., Angiotensin converting enzyme inhibitors or angiotensin II receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Rev Med Liège, 2006, 61, 414-422. [Google Scholar]
  • Ludwig J., Kerscher S., Brandt U., Pfeiffer K., Getlawi F., Apps D.K., Schägger H., Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J Biol Chem, 1998, 273, 10939-10947. [CrossRef] [PubMed] [Google Scholar]
  • Luetscher J.A., Kraemer F.B., Wilson D.M., Schwartz H.C., Bryer-Ash M., Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med, 1985, 312, 1412-1417. [CrossRef] [PubMed] [Google Scholar]
  • Maru I., Ohta Y., Murata K., Tsukada Y., Molecular cloning and identification of N-acyl-D-glucosamine 2-epimerase from porcine kidney as a renin-binding protein. J Biol Chem., 1996, 271, 16294-16299. [CrossRef] [PubMed] [Google Scholar]
  • Methot D., Silversides D.W., Reudelhuber T.L., In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ Res, 1999, 84, 1067-1072. [PubMed] [Google Scholar]
  • Nagai N., Noda K., Urano T., Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci, 2005, 46, 1078-1084. [CrossRef] [PubMed] [Google Scholar]
  • Nguyen G., Delarue F., Berrou J., Rondeau E., Sraer J.D., Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int, 1996, 50, 1897-1903. [CrossRef] [PubMed] [Google Scholar]
  • Nguyen G., Delarue F., Burcklé C., Bouzhir L., Giller T., Sraer J.D., Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest, 2002, 109, 1417-1427. [PubMed] [Google Scholar]
  • Prescott G., Silversides D.W., Reudelhuber T.L., Tissue activity of circulating prorenin. Am J Hypertens, 2002, 15, 280-285. [CrossRef] [PubMed] [Google Scholar]
  • Ramser J., Abidi F.E., Burckle C.A., Lenski C., Toriello H., Wen G., Lubs H.A., Engert S., Stevenson R.E., Meindl A., Schwartz C.E., Nguyen G., A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet, 2005, 14, 1019-1027. [CrossRef] [PubMed] [Google Scholar]
  • Saris J.J., Derkx F.H., De Bruin R.J., Dekkers D.H., Lamers J.M., Saxena P.R., Schalekamp M.A., Jan Danser A.H., High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol Heart Circ Physiol, 2001, 280, H1706-1715. [PubMed] [Google Scholar]
  • Saris J.J., van den Eijnden M.M., Lamers J.M., Saxena P.R., Schalekamp M.A., Danser A.H., Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II. Hypertension, 2002, 39, 573–577. [CrossRef] [PubMed] [Google Scholar]
  • Saris J.J., t'Hoen P.A., Garrelds I.M., Dekkers D.H., den Dunnen J.T., Lamers J.M., Jan Danser A.H., Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension, 2006, 48, 564-571 [Google Scholar]
  • Satofuka S., Ichihara A., Nagai N., Yamashiro K., Koto T., Shinoda H., Noda K., Ozawa Y., Inoue M., Tsubota K., Suzuki F., Oike Y., Ishida S., Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci, 2006, 47, 2686-2692. [CrossRef] [PubMed] [Google Scholar]
  • Satofuka S., Ichihara A., Nagai N., Tsubota K., Itoh H., Ishida S., Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci, 2007, 48, 422-429. [CrossRef] [PubMed] [Google Scholar]
  • Satofuka S., Ichihara A., Nagai N., Noda K., Ozawa Y., Fukamizu A., Tsubota K., Itoh H., Oike Y., Ishida S., (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. Am J Pathol, 2008, 173, 1911-1918. [CrossRef] [PubMed] [Google Scholar]
  • Schefe J.H., Menk M., Reinemund J., Effertz K., Hobbs R.M., Pandolfi P.P., Ruiz P., Unger T., Funke-Kaiser H., A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res, 2006, 99, 1355-66. [CrossRef] [PubMed] [Google Scholar]
  • Schmitz C., Gotthardt M., Hinderlich S., Leheste J.R., Gross V., Vorum H., Christensen E.I., Luft F.C., Takahashi S., Willnow T.E., Normal blood pressure and plasma renin activity in mice lacking the renin-binding protein, a cellular renin inhibitor. J Biol Chem, 2000, 275, 15357-15362 [Google Scholar]
  • Sealey J.E., Catanzaro D.F., Lavin T.N., Gahnem F., Pitarresi T., Hu L.F., Laragh J.H., Specific prorenin/renin binding (ProBP). Identification and characterization of a novel membrane site. Am J Hypertens, 1996, 9, 491-502. [CrossRef] [PubMed] [Google Scholar]
  • Takahashi S., Inoue H., Miyake Y., The human gene for renin-binding protein. J Biol Chem, 1992, 267, 13007-13013. [PubMed] [Google Scholar]
  • Véniant M., Ménard J., Bruneval P., Morley S., Gonzales M.F., Mullins J., Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest, 1996, 98, 1966-1970. [CrossRef] [PubMed] [Google Scholar]
  • von Lutterotti N., Catanzaro D.F., Sealey J.E., Laragh J.H., Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation, 1994, 89, 458-470. [PubMed] [Google Scholar]
  • Wilkinson-Berka J.L., Prorenin and the (pro)renin receptor in ocular pathology. Am J Pathol, 2008, 173, 1591-1594. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.